Citigroup »

Sutro Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $469k 19k 24.91

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Sutro Biopharma

BVF
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Vanguard Capital Management
RA Capital Management
Perceptive Advisors
Point72 Asset Management
ADAR1 Capital Management
Balyasny Asset Management
Woodline Partners
UBS Group
Vanguard Group
Acadian Asset Management

View all funds holding Sutro Biopharma